Some of the top parks and other open spaces and services in Portland, Oregon, that provide great offsite options for meetings ...

Layoffs have hit companies from HPE to Meta and Boeing already this year amid a backdrop of cost-cutting and technological ...

The “dramatic and unfortunate end” of Adidas AG‘s partnership with the designer and rapper Kanye West and his Yeezy ...

THE HAPA BLONDE The Adidas Taekwondo isn’t just a celebrity favorite—it’s also having a full-on fashion editor moment. I grabbed a pair earlier this year, and as someone who typically loves ...

Harden began his career with Nike before signing a massive 13-year, $200 million signature sneaker deal with adidas in 2015. The 11-time NBA All-Star wants to go even bigger with his next contract.

In a company-wide memo seen by Reuters, Tan outlined a flattening of the corporate hierarchy intended to accelerate decision-making and sharpen Intel’s focus on engineering and innovation.

Unlike traditional training models, InStride partners with healthcare providers to develop clinical cohorts tailored to address specific workforce needs. By combining structured online learning with ...

you still have a hierarchy, and you still have to have people, strong people making strong decisions. “I feel too often, they follow what they hear outside. To me, that is not a healthy way to ...

Jenna Sundel is a Newsweek reporter based in New Jersey. Her focus is reporting on breaking news. She has in-depth knowledge of crime and courts. Jenna joined Newsweek in 2024. She previously ...

risks related to the Corporation's corporate structure; foreign exchange and pricing risks; credit risks; competition in product markets; future market access; interest rate changes; risks in ...

and strengthen the Corporation’s capital structure (the "CBCA Transaction") pursuant to which, among other things, the Corporation’s previously outstanding 8.50% senior second lien secured ...

17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and ...